EUVIMEDEUVIMED entdecken
Open Access

Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis

Mohamed-Salah Annabi, Rasmus Carter-Storch, Amira Zaroui, Arnault Galat iD, Silvia Oghina iD, Mounira Kharoubi, Mélanie Bezard, Geneviève Derumeaux iD, Pascale Fanen iD, François Lemonnier, Elsa Poullot, Emmanuel Itti iD und 5 weitere

Journal of the American Heart Association · 02.07.2024 · 13 (13)

DOI: 10.1161/jaha.124.034723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 02.07.2024. Verfasst von Mohamed-Salah Annabi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institut Universitaire de Cardiologie et de Pneumologie Université Laval Québec Canada. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Cardiomyopathies, Registries. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac amyloidosis (CA) is frequently found in older patients with aortic stenosis (AS). However, the prevalence of AS among patients with CA is unknown. The objective was to study the prevalence and prognostic impact of AS among patients with CA. Methods and Results We conducted a retrospective analysis of a prospective registry comprising 976 patients with native aortic valves who were confirmed with wild type transthyretin amyloid (ATTRwt), hereditary variant transthyretin amyloid (ATTRv), or immunoglobulin light‐chain (AL) CA. CA patients' echocardiograms were re‐analyzed focusing on the aortic valve. Multivariable Cox regression analysis was performed to assess the mortality risk associated with moderate or greater AS in ATTRwt CA. The crude prevalence of AS among patients with CA was 26% in ATTRwt, 8% in ATTRv, and 5% in AL. Compared with population‐based controls, all types of CA had higher age‐ and sex‐standardized rate ratios (SRRs) of having any degree of AS (AL: SRR, 2.62; 95% Confidence Interval (CI) [1.09–3.64]; ATTRv: SRR, 3.41; 95%CI [1.64–4.60]; ATTRwt: SRR, 10.8; 95%CI [5.25–14.53]). Compared with hospital controls, only ATTRwt had a higher SRR of having any degree of AS (AL: SRR, 0.97, 95%CI [0.56–1.14]; ATTRv: SRR, 1.27; 95%CI [0.85–1.44]; ATTRwt: SRR, 4.01; 95%CI [2.71–4.54]). Among patients with ATTRwt, moderate or greater AS was not associated with increased all‐cause death after multivariable adjustment (hazard ratio, 0.71; 95%CI [0.42–1.19]; P =0.19).

Conclusions

Among patients with CA, ATTRwt but not ATTRv or AL is associated with a higher prevalence of patients with AS compared with hospital controls without CA, even after adjusting for age and sex. In our population, having moderate or greater AS was not associated with a worse outcome in patients with ATTRwt.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisCardiomyopathiesRegistriesHumansMaleFemalePrevalenceAgedRetrospective StudiesPrognosisAged, 80 and overAmyloid Neuropathies, FamilialRisk FactorsEchocardiographyMiddle AgedAmyloidosisImmunoglobulin Light-chain AmyloidosisPrealbuminAortic Valve

Stichwörter der Autor:innen

aortic stenosiscardiac amyloidosisechocardiographyprognosistransthyretin

Substanzen

TTR protein, humanPrealbumin

Autor:innen und Institutionen

  • Institut Universitaire de Cardiologie et de Pneumologie Université Laval Québec Canada.
  • Referral Center for Cardiac Amyloidosis, Mondor Amyloidosis Network, GRC Amyloid Research Institute and Cardiology Department APHP Henri Mondor Hospital Créteil France.
  • INSERM U955, Team «Senescence, Metabolism and Cardiovascular Diseases» Paris-Est Créteil University (UPEC) Créteil France.
  • Department of Cardiology Odense University Hospital Odense Denmark.
  • INSERM Unit U955 Clinical Epidemiology and Ageing (CEpiA, Paris-Est Créteil University, Val-de-Marne) Créteil France.
  • AP-HP, Department of Physiology Henri Mondor Hospital, FHU-SENEC Créteil France.

ORCID-Profile: Arnault Galat, Silvia Oghina, Geneviève Derumeaux, Pascale Fanen, Emmanuel Itti, Philippe Pibarot, Thibaud Damy, Marie-Annick Clavel

Zitieren

APA

Annabi, M. S., Carter-Storch, R., Zaroui, A., Galat, A., Oghina, S., Kharoubi, M., Bezard, M., Derumeaux, G., Fanen, P., Lemonnier, F., Poullot, E., Itti, E., Gallet, R., Teiger, E., Pibarot, P., Damy, T., & Clavel, M. A. (2024). Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis. Journal of the American Heart Association, 13(13). https://doi.org/10.1161/jaha.124.034723

Vancouver

Annabi MS, Carter-Storch R, Zaroui A, Galat A, Oghina S, Kharoubi M, et al. Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis. Journal of the American Heart Association. 2024;13(13). doi:10.1161/jaha.124.034723

BibTeX
@article{Annabi2024,
  author = {Annabi, Mohamed-Salah and Carter-Storch, Rasmus and Zaroui, Amira and Galat, Arnault and Oghina, Silvia and Kharoubi, Mounira and Bezard, Mélanie and Derumeaux, Geneviève and Fanen, Pascale and Lemonnier, François and Poullot, Elsa and Itti, Emmanuel and Gallet, Romain and Teiger, Emmanuel and Pibarot, Philippe and Damy, Thibaud and Clavel, Marie-Annick},
  title = {Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {13},
  doi = {10.1161/jaha.124.034723}
}
Kostenlos starten →